Follow
Dr. Prince Anand, Ph.D.
Dr. Prince Anand, Ph.D.
Postdoctoral Scientist, Samuel Oschin Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA
Verified email at cshs.org - Homepage
Title
Cited by
Cited by
Year
MAPKAPK2: the master regulator of RNA-binding proteins modulates transcript stability and tumor progression
S Soni, P Anand, YS Padwad
Journal of Experimental & Clinical Cancer Research 38 (1), 121, 2019
1122019
Myxobacteria: unraveling the potential of a unique microbiome niche
P Thakur, C Chopra, P Anand, DS Dhanjal, RS Chopra
Microbial Bioprospecting for Sustainable Development, 137-163, 2018
92018
DNA damage response proteins synergistically affect the cancer prognosis and resistance
M Sharma, P Anand, YS Padwad, V Dogra, V Acharya
Free Radical Biology and Medicine 178, 174-188, 2022
82022
Accessing the microbial diversity of sugarcane fields from Gujjarwal village, Ludhiana and their molecular identification
DS Dhanjal, C Chopra, P Anand, RS Chopra
Research Journal of Pharmacy and Technology 10 (10), 3439-3442, 2017
82017
Isolation and characterization of microbial diversity of soil of Dhanbad coal mines using molecular approach
P Anand, RS Chopra, DS Dhanjal, C Chopra
Research Journal of Pharmacy and Technology 12 (3), 1137-1140, 2019
72019
MAPKAPK2-centric transcriptome profiling reveals its major role in governing molecular crosstalk of IGFBP2, MUC4, and PRKAR2B during HNSCC pathogenesis
S Soni, P Anand, MK Swarnkar, V Patial, NV Tirpude, YS Padwad
Computational and Structural Biotechnology Journal 21, 1292-1311, 2023
32023
Novel 3-methyleneisoindolinones diversified via intramolecular heck cyclization induce oxidative stress, decrease mitochondrial membrane potential, disrupt cell cycle, and …
A Sharma, P Anand, YS Padwad, SK Maurya
ACS omega 7 (49), 45036-45044, 2022
32022
Metagenomic signatures reveal the key role of Phloretin in amelioration of gut dysbiosis attributed to metabolic-dysfunction associated fatty liver disease (MAFLD) by …
J Chhimwal, P Anand, P Mehta, MK Swarnkar, V Patial, R Pandey, ...
Frontiers in Microbiology 14, 1210517, 2023
12023
Targeted Molecular Therapies in Cancer
P Anand, S Soni, YS Padwad
Mod. Cancer Ther. Tradit. Med. An Integr. Approach to Combat Cancers, 59-101, 2021
12021
Amorphous solid dispersion augments the bioavailability of phloretin and its therapeutic efficacy via targeting mTOR/SREBP-1c axis in NAFLD mice
J Chhimwal, RK Dhritlahre, P Anand, V Patial, A Saneja, YS Padwad
Biomaterials Advances 154, 213627, 2023
2023
Novel pyrrolone-fused benzosuberene MK2 inhibitors: synthesis, pharmacophore modelling, molecular docking, and anti-cancer efficacy evaluation in HNSCC cells
Yamini, P Anand, VK Bhardwaj, A Kumar, R Purohit, P Das, Y Padwad
Journal of Biomolecular Structure and Dynamics 41, 1-22, 2023
2023
Styryl-cinnamate hybrid inhibits glioma by alleviating translation, bioenergetics and other key cellular responses leading to apoptosis
K Rawat, A Shard, M Jadhav, M Gandhi, P Anand, R Purohit, Y Padwad, ...
Experimental Cell Research 375 (1), 11-21, 2019
2019
MAPKAPK2 regulates the progression of head and neck squamous cell carcinoma by stabilizing TNF-α, VEGF and destabilizing p27, MKP-1 transcripts
S Soni, P Anand, YS Padwad
CANCER MEDICINE 7, 53-53, 2018
2018
The system can't perform the operation now. Try again later.
Articles 1–13